STipe Therapeutics Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
24
- Latest Deal Type
-
Liquidation
STipe Therapeutics General Information
Description
Operator of a biopharmaceutical company designed to harness the innate immune system to battle cancer. The company offers first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway, enabling oncology professionals to modulate the tumor microenvironment and enhance anti-tumoral responses.
Contact Information
Website
www.stipetherapeutics.comCorporate Office
- Gorrissen Federspiel
- Axeltorv 2
- 1609 Copenhagen
- Denmark
Corporate Office
- Gorrissen Federspiel
- Axeltorv 2
- 1609 Copenhagen
- Denmark
STipe Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Bankruptcy: Liquidation | 01-Oct-2023 | Completed | Bankruptcy: Liquidation | |||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Early Stage VC (Series A) | 30-Sep-2019 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jun-2018 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 2. Grant | 01-Jan-2018 | $1.59M | Completed | Startup | ||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
STipe Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 37,036 | $118.52 | $118.52 | 1x | $118.52 | 15.46% | ||
| Ordinary | 78,388 | $119 | $119 | 1x | $119 | 32.73% |
STipe Therapeutics Comparisons
Industry
Financing
Details
STipe Therapeutics Competitors (56)
One of STipe Therapeutics’s 56 competitors is Iovance Biotherapeutics, a Corporation company based in San Carlos, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA | ||||
| MonTa BioSciences | Venture Capital-Backed | Lyngby, Denmark |
STipe Therapeutics Patents
STipe Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4445917-A1 | Sting sensitising agents | Inactive | 14-Apr-2023 | ||
| EP-4445918-A1 | Sting sensitising agents | Inactive | 14-Apr-2023 | ||
| WO-2024213783-A1 | Sting sensitising agents | Inactive | 14-Apr-2023 | ||
| US-20240350647-A1 | Sting sensitizing agents | Inactive | 14-Apr-2023 | ||
| WO-2022003152-A2 | Compositions comprising extracellular vesicles and sting stimulatory agents | Inactive | 03-Jul-2020 | C12N5/0636 |
STipe Therapeutics Signals
STipe Therapeutics FAQs
-
When was STipe Therapeutics founded?
STipe Therapeutics was founded in 2018.
-
Where is STipe Therapeutics headquartered?
STipe Therapeutics is headquartered in Copenhagen, Denmark.
-
What is the size of STipe Therapeutics?
STipe Therapeutics has 24 total employees.
-
What industry is STipe Therapeutics in?
STipe Therapeutics’s primary industry is Drug Discovery.
-
Is STipe Therapeutics a private or public company?
STipe Therapeutics is a Private company.
-
What is STipe Therapeutics’s current revenue?
The current revenue for STipe Therapeutics is .
-
How much funding has STipe Therapeutics raised over time?
STipe Therapeutics has raised $22.5M.
-
Who are STipe Therapeutics’s competitors?
Iovance Biotherapeutics, Adaptimmune Therapeutics, Cristal Therapeutics, Selecta Biosciences, and MonTa BioSciences are some of the 56 competitors of STipe Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process